Press Release

View printer-friendly version << Back
Columbia Laboratories to participate in the Rodman & Renshaw 16th Annual Global Investment Conference

BOSTON, Aug. 27, 2014 /PRNewswire/ -- Columbia Laboratories, Inc. (Nasdaq: CBRX) ("Columbia" or "the Company"), a provider of pharmaceutical development, clinical trial manufacturing, and advanced analytical and consulting services to the pharmaceutical industry, today announced that it will participate at the upcoming Rodman & Renshaw 16th Annual Global Investment Conference, to be held in New York. The Company will present at the conference at 11:15am on September 9, 2014 at the New York Palace Hotel.

To access a live webcast of the presentation, visit http://wsw.com/webcast/rrshq24/cbrx.

About Columbia Laboratories

Columbia Laboratories, Inc. provides pharmaceutical development, clinical trial manufacturing, and advanced analytical and consulting services to the pharmaceutical industry. The Company has a successful heritage in developing pharmaceutical products, particularly in women's health. Its most successful product to date, CRINONE® 8% (progesterone gel), is marketed by Actavis, Inc. in the U.S. and by Merck Serono S.A. in over 60 additional countries worldwide. For more information, please visit www.columbialabs.com.

Investor Relations Contact:
MBS Value Partners
Katja Buhrer
+212 661 7004
katja.buhrer@mbsvalue.com

SOURCE Columbia Laboratories, Inc.